GTE-001

N/A

Report date: 2026/04/21 20:00:18

Base Information

Drug NameGTE-001

Drug Alias NameGTE001GTE-001

ClassificationCell and gene therapy > Cell therapy > Immune system cell therapy > Lymphocytes therapy > T-lymphocyte cell therapy > Tumor Infiltrating Lymphocytes

Mechanisms of ActionT lymphocyte replacements

TargetsNot applicable

Therapy Area/IndicationsAdenocarcinoma of Lung

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryMainland China

CombinationsNo

Global Highest StatusDiscontinued (Phase 1 Clinical)

Highest Status in ChinaDiscontinued

Originator Companiesshenzhen Grit Biotechnology Co Ltd

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive Companiesshenzhen Grit Biotechnology Co Ltd

Active IndicationsN/A

Inactive IndicationsAdenocarcinoma of Lung

Other Information

ATC CodeN/A